Methodological challenges in the analysis of recurrent events for randomised controlled trials with application to cardiovascular events in LEADER

A tutorial on frailty models

(2020) Theodor A Balan et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT

(2019) Deepak L. Bhatt et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

(2019) Scott D. Solomon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events

(2019) Subodh Verma et al.   JAMA Cardiology

Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)

(2018) Ulrik M. Mogensen et al.   EUROPEAN JOURNAL OF HEART FAILURE

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

(2016) Steven P. Marso et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety data from randomized controlled trials: applying models for recurrent events

(2016) Johannes Hengelbrock et al.   PHARMACEUTICAL STATISTICS

Semiparametric regression for the weighted composite endpoint of recurrent and terminal events

(2015) Lu Mao et al.   BIOSTATISTICS

frailtypack: AnRPackage for the Analysis of Correlated Survival Data with Frailty Models Using Penalized Likelihood Estimation or Parametrical Estimation

(2015) Virginie Rondeau et al.   Journal of Statistical Software

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved

(2014) Jennifer K. Rogers et al.   EUROPEAN JOURNAL OF HEART FAILURE

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Time to move on from 'time-to-first': should all events be included in the analysis of clinical trials?

(2012) S. D. Anker et al.   EUROPEAN HEART JOURNAL

Competing risks in epidemiology: possibilities and pitfalls

(2012) Per Kragh Andersen et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities

(2011) S. J. Pocock et al.   EUROPEAN HEART JOURNAL